Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its first quarter 2025 financial results announcement and corporate update for Thursday, May 1, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can access the webcast through the company's website, where a recorded version will be available shortly after the event and remain accessible for approximately 90 days.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 e un aggiornamento aziendale per giovedì 1 maggio 2025. La società trasmetterà una diretta web alle 13:30 PT / 16:30 ET. Gli interessati potranno accedere alla diretta tramite il sito web dell'azienda, dove sarà disponibile una registrazione poco dopo l'evento e rimarrà accessibile per circa 90 giorni.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programado el anuncio de resultados financieros del primer trimestre de 2025 y una actualización corporativa para el jueves 1 de mayo de 2025. La compañía ofrecerá una transmisión en vivo a la 1:30 p.m. PT / 4:30 p.m. ET. Los interesados podrán acceder a la transmisión a través del sitio web de la empresa, donde estará disponible una versión grabada poco después del evento y permanecerá accesible durante aproximadamente 90 días.
Tarsus Pharmaceuticals (NASDAQ: TARS)는 2025년 1분기 재무 실적 발표 및 기업 업데이트를 2025년 5월 1일 목요일로 예정했습니다. 회사는 오후 1시 30분 PT / 오후 4시 30분 ET에 라이브 웹캐스트를 진행할 예정입니다. 관심 있는 참가자는 회사 웹사이트를 통해 웹캐스트에 접속할 수 있으며, 행사 직후 녹화본이 제공되어 약 90일간 이용할 수 있습니다.
Tarsus Pharmaceuticals (NASDAQ : TARS) a programmé l'annonce de ses résultats financiers du premier trimestre 2025 ainsi qu'une mise à jour d'entreprise pour le jeudi 1er mai 2025. La société organisera une webdiffusion en direct à 13h30 PT / 16h30 ET. Les personnes intéressées pourront accéder à la diffusion en direct via le site internet de l'entreprise, où une version enregistrée sera disponible peu après l'événement et restera accessible pendant environ 90 jours.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 und ein Unternehmensupdate für Donnerstag, den 1. Mai 2025, angesetzt. Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET ein Live-Webcast veranstalten. Interessierte Teilnehmer können über die Website des Unternehmens auf das Webcast zugreifen, wo kurz nach der Veranstaltung eine Aufzeichnung verfügbar sein wird, die etwa 90 Tage lang abrufbar bleibt.
- None.
- None.
IRVINE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Thursday, May 1, 2025, to report its first quarter 2025 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus Pharmaceuticals (TARS) release Q1 2025 earnings?
How can investors access the TARS Q1 2025 earnings call?
How long will the TARS Q1 2025 earnings call recording be available?
What will be discussed in the TARS May 1, 2025 webcast?
